Clinical trial
A Prospective, Randomized Trial of the Effect of Standard of Care Reduced Dose Versus Full Dose Buprenorphine/Naloxone in the Perioperative Period on Pain Control and Post Operative Opioid Use Disorder Symptoms
NCT03266445 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Randomized Trial of the Effect of Standard of Care Reduced Dose Versus Full Dose Buprenorphine/Naloxone in the Perioperative Period on Pain Control and Post Operative Opioid Use Disorder Symptoms
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- October 5, 2018
- Completion date
- February 26, 2022
- Enrollment
- 76 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
opioid-use disorder, pain, acute, surgery